Final Drop?This looks like the final puke of wave 5. It could end up anywhere between $40-50. I have taken a position at $50 and I intend to load up more if we retest the historical support trendline.
Not financial advice, do what's best for you
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.146 EUR
13.50 B EUR
38.82 B EUR
3.16 B
About NOVO NORDISK B A/S
Sector
Industry
CEO
Lars Fruergaard Jørgensen
Website
Headquarters
Bagsværd
Founded
1931
ISIN
DK0062498333
FIGI
BBG000RYSN40
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Related stocks
$NVO Accumulating long term compounder! - Previously, I have shorted NYSE:NVO when it was in $75-85 when moat was weakening and then went long around $58 to $75 for 40% on the long side. Everything is documented in my two posts.
- People are asking me if NYSE:NVO is cheap or not. After cutting guidance, I believe most of the estimat
Fib resistance + RSI bullish reversal After the bearish news earlier today, it seems like Novo has had its final capitulation.
There's a fib resistance + historical resistance dating back to '21-'22.
On the weekly, the RSI is also presenting a bullish divergence - although we may want to await the closing of this week to confirm this.
T
NVO Are we about to make trend reversal here?The Price action of NVO has been retested and bounce up from the 100 monthly EMA trendline.
With previous weekly bullish enhulfing candle.
So far possibly price structure for trend reversal to the upside, let see how this will play out.
NVO going to zero? Just zoom out V.2While many are panic, just zoom out years and we can dee that it is at 30 years support trend line to the upside.
Weekly RSI printing bullishvergent, monthly at Oversold level.
Still fundamentally strong, If you love this stock, be excited.
(Last post chart didn't appear properly, I couldn't edit
ALL-IN NOVO!!!We have reached a significant demand zone from which we shall accumulate some buy orders. Expecting this stock to turn around from this zone and break into new all-time-highs.
NVO-Bought more hereDoubled down right here,
Testing the all time support trendline 100 monthly SMA.
Is Novo Nordisk a buy? Novo Nordisk $NYSE: NVO plummets 22% on July 29, wiping out $57.5B in market value!
Here's what's happening and how I see it.
Here’s the breakdown on why the stock hit its lowest since Nov 2022:
Slashed 2025 Guidance: Sales growth cut to 8–14% from 13–21%, operating profit to 10–16% from 16–2
NVO Could Bounce Back Soon ?!NVO dropped hard (over 20%) mainly because of a legal issue. I think this is temporary and will get solved with time. The stock is now super oversold and sitting on strong support around $52–53.
• Entry: $52–54
• Target 1: $56.90
• Target 2: $66.40
• Stop Loss: $50
If the issue clears, we could
Novo Nordisk, generational buying opportunity? Novo Nordisk is currently experiencing one of the largest drawdowns in its history, primarily triggered by a downward revision of guidance for FY25 and FY26.
Focusing strictly on technical analysis:
For the first time, the monthly 200 EMA is serving as a key support level for Novo Nordisk -
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NOV is featured.
Frequently Asked Questions
The current price of NOV is 41.715 EUR — it has decreased by −2.46% in the past 24 hours. Watch NOVO NORDISK A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange NOVO NORDISK A/S stocks are traded under the ticker NOV.
NOV stock has fallen by −33.48% compared to the previous week, the month change is a −32.46% fall, over the last year NOVO NORDISK A/S has showed a −66.09% decrease.
We've gathered analysts' opinions on NOVO NORDISK A/S future price: according to them, NOV price has a max estimate of 100.25 EUR and a min estimate of 40.10 EUR. Watch NOV chart and read a more detailed NOVO NORDISK A/S stock forecast: see what analysts think of NOVO NORDISK A/S and suggest that you do with its stocks.
NOV stock is 6.37% volatile and has beta coefficient of 1.44. Track NOVO NORDISK A/S stock price on the chart and check out the list of the most volatile stocks — is NOVO NORDISK A/S there?
Today NOVO NORDISK A/S has the market capitalization of 186.70 B, it has decreased by −4.87% over the last week.
Yes, you can track NOVO NORDISK A/S financials in yearly and quarterly reports right on TradingView.
NOVO NORDISK A/S is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
NOV earnings for the last quarter are 0.87 EUR per share, whereas the estimation was 0.82 EUR resulting in a 6.95% surprise. The estimated earnings for the next quarter are 0.79 EUR per share. See more details about NOVO NORDISK A/S earnings.
NOVO NORDISK A/S revenue for the last quarter amounts to 10.46 B EUR, despite the estimated figure of 10.44 B EUR. In the next quarter, revenue is expected to reach 10.26 B EUR.
NOV net income for the last quarter is 3.89 B EUR, while the quarter before that showed 3.77 B EUR of net income which accounts for 3.03% change. Track more NOVO NORDISK A/S financial stats to get the full picture.
NOVO NORDISK A/S dividend yield was 1.83% in 2024, and payout ratio reached 50.28%. The year before the numbers were 1.35% and 50.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 1, 2025, the company has 76.3 K employees. See our rating of the largest employees — is NOVO NORDISK A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVO NORDISK A/S EBITDA is 21.00 B EUR, and current EBITDA margin is 50.95%. See more stats in NOVO NORDISK A/S financial statements.
Like other stocks, NOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVO NORDISK A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVO NORDISK A/S technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVO NORDISK A/S stock shows the sell signal. See more of NOVO NORDISK A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.